This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbolla, R.
Right arrow Articles by Piñeiro, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbolla, R.
Right arrow Articles by Piñeiro, S. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2004, p. 666-669, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.666-669.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Class 1 Integrons Increase Trimethoprim-Sulfamethoxazole MICs against Epidemiologically Unrelated Stenotrophomonas maltophilia Isolates

Raquel Barbolla,1 Mariana Catalano,1 Betina E. Orman,1 Angela Famiglietti,2 Carlos Vay,2 Jorgelina Smayevsky,3 Daniela Centrón,1* and Silvia A. Piñeiro1,{dagger}

Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina,1 Laboratorio de Bacteriología, Departamento de Análisis Clínicos, Hospital de Clínicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires,2 Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina3

Received 30 December 2002/ Returned for modification 16 May 2003/ Accepted 2 November 2003

Twenty-five plasmid-specified antimicrobial resistance determinants common to gram-negative bacilli from nosocomial infection were investigated from 31 Stenotrophomonas maltophilia isolates. Twenty-four clones were identified by pulsed-field gel electrophoresis, and in three clones that exhibited an increased trimethoprim-sulfamethoxazole MIC, the sul1 determinant was found. These results support not only the higher spread of class 1 integrons compared to other mechanisms but also the potential limitation of using trimethoprim-sulfamethoxazole for therapy of severe S. maltophilia infections.


* Corresponding author. Mailing address: Dept. Microbiología, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, P-12, 1121 Buenos Aires, Argentina. Phone: 54 11 4963 6669. Fax: 54 11 4508 3705. E-mail: dcentron{at}fmed.uba.ar.

{dagger} Present address: Department of Biomedical Sciences, University of Maryland, Baltimore, MD 21201.


Antimicrobial Agents and Chemotherapy, February 2004, p. 666-669, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.666-669.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Falagas, M. E., Valkimadi, P.-E., Huang, Y.-T., Matthaiou, D. K., Hsueh, P.-R. (2008). Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother 62: 889-894 [Abstract] [Full Text]  
  • Chang, L.-L., Lin, H.-H., Chang, C.-Y., Lu, P.-L. (2007). Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 59: 1038-1039 [Full Text]  
  • Gould, V. C., Avison, M. B. (2006). SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J Antimicrob Chemother 57: 1070-1076 [Abstract] [Full Text]  
  • Navarro-Martinez, M. D., Navarro-Peran, E., Cabezas-Herrera, J., Ruiz-Gomez, J., Garcia-Canovas, F., Rodriguez-Lopez, J. N. (2005). Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 49: 2914-2920 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]